189 related articles for article (PubMed ID: 37184233)
1. Asymmetric activation of dimeric GABA
Liu L; Lin L; Shen C; Rondard P; Pin JP; Xu C; Liu J
Am J Physiol Cell Physiol; 2023 Jul; 325(1):C79-C89. PubMed ID: 37184233
[TBL] [Abstract][Full Text] [Related]
2. Allosteric control of an asymmetric transduction in a G protein-coupled receptor heterodimer.
Liu J; Zhang Z; Moreno-Delgado D; Dalton JA; Rovira X; Trapero A; Goudet C; Llebaria A; Giraldo J; Yuan Q; Rondard P; Huang S; Liu J; Pin JP
Elife; 2017 Aug; 6():. PubMed ID: 28829739
[TBL] [Abstract][Full Text] [Related]
3. Organization and functions of mGlu and GABA
Pin JP; Bettler B
Nature; 2016 Dec; 540(7631):60-68. PubMed ID: 27905440
[TBL] [Abstract][Full Text] [Related]
4. The complexity of their activation mechanism opens new possibilities for the modulation of mGlu and GABAB class C G protein-coupled receptors.
Rondard P; Goudet C; Kniazeff J; Pin JP; Prézeau L
Neuropharmacology; 2011 Jan; 60(1):82-92. PubMed ID: 20713070
[TBL] [Abstract][Full Text] [Related]
5. G-protein-coupled receptor oligomers: two or more for what? Lessons from mGlu and GABAB receptors.
Pin JP; Comps-Agrar L; Maurel D; Monnier C; Rives ML; Trinquet E; Kniazeff J; Rondard P; Prézeau L
J Physiol; 2009 Nov; 587(Pt 22):5337-44. PubMed ID: 19723778
[TBL] [Abstract][Full Text] [Related]
6. Allosteric ligands control the activation of a class C GPCR heterodimer by acting at the transmembrane interface.
Liu L; Fan Z; Rovira X; Xue L; Roux S; Brabet I; Xin M; Pin JP; Rondard P; Liu J
Elife; 2021 Dec; 10():. PubMed ID: 34866572
[TBL] [Abstract][Full Text] [Related]
7. [Recent advances in the structural biology of the class C G protein-coupled receptors: The metabotropic Glutamate receptor 5].
Berto L; Dumazer A; Malhaire F; Cannone G; Kutti Ragunath V; Goudet C; Lebon G
Biol Aujourdhui; 2021; 215(3-4):85-94. PubMed ID: 35275053
[TBL] [Abstract][Full Text] [Related]
8. Allosteric modulation of metabotropic glutamate receptors.
Sheffler DJ; Gregory KJ; Rook JM; Conn PJ
Adv Pharmacol; 2011; 62():37-77. PubMed ID: 21907906
[TBL] [Abstract][Full Text] [Related]
9. Molecular Switches of Allosteric Modulation of the Metabotropic Glutamate 2 Receptor.
Pérez-Benito L; Doornbos MLJ; Cordomí A; Peeters L; Lavreysen H; Pardo L; Tresadern G
Structure; 2017 Jul; 25(7):1153-1162.e4. PubMed ID: 28648611
[TBL] [Abstract][Full Text] [Related]
10. Computational Drug Design Applied to the Study of Metabotropic Glutamate Receptors.
Llinas Del Torrent C; Pérez-Benito L; Tresadern G
Molecules; 2019 Mar; 24(6):. PubMed ID: 30897742
[TBL] [Abstract][Full Text] [Related]
11. Structure, pharmacology and therapeutic prospects of family C G-protein coupled receptors.
Bräuner-Osborne H; Wellendorph P; Jensen AA
Curr Drug Targets; 2007 Jan; 8(1):169-84. PubMed ID: 17266540
[TBL] [Abstract][Full Text] [Related]
12. Photoswitchable allosteric modulators for metabotropic glutamate receptors.
Gómez-Santacana X; Panarello S; Rovira X; Llebaria A
Curr Opin Pharmacol; 2022 Oct; 66():102266. PubMed ID: 35870289
[TBL] [Abstract][Full Text] [Related]
13. Allosteric modulation of metabotropic glutamate receptors in alcohol use disorder: Insights from preclinical investigations.
Johnson KA; Lovinger DM
Adv Pharmacol; 2020; 88():193-232. PubMed ID: 32416868
[TBL] [Abstract][Full Text] [Related]
14. Practical Strategies and Concepts in GPCR Allosteric Modulator Discovery: Recent Advances with Metabotropic Glutamate Receptors.
Lindsley CW; Emmitte KA; Hopkins CR; Bridges TM; Gregory KJ; Niswender CM; Conn PJ
Chem Rev; 2016 Jun; 116(11):6707-41. PubMed ID: 26882314
[TBL] [Abstract][Full Text] [Related]
15. Structural, signalling and regulatory properties of the group I metabotropic glutamate receptors: prototypic family C G-protein-coupled receptors.
Hermans E; Challiss RA
Biochem J; 2001 Nov; 359(Pt 3):465-84. PubMed ID: 11672421
[TBL] [Abstract][Full Text] [Related]
16. Distinct roles of metabotropic glutamate receptor dimerization in agonist activation and G-protein coupling.
El Moustaine D; Granier S; Doumazane E; Scholler P; Rahmeh R; Bron P; Mouillac B; Banères JL; Rondard P; Pin JP
Proc Natl Acad Sci U S A; 2012 Oct; 109(40):16342-7. PubMed ID: 22988116
[TBL] [Abstract][Full Text] [Related]
17. Structure-based discovery and development of metabotropic glutamate receptor 5 negative allosteric modulators.
Bennett KA; Christopher JA; Tehan BG
Adv Pharmacol; 2020; 88():35-58. PubMed ID: 32416871
[TBL] [Abstract][Full Text] [Related]
18. Allosteric Modulators of Metabotropic Glutamate Receptors as Novel Therapeutics for Neuropsychiatric Disease.
Luessen DJ; Conn PJ
Pharmacol Rev; 2022 Jul; 74(3):630-661. PubMed ID: 35710132
[TBL] [Abstract][Full Text] [Related]
19. Neuropharmacological Insight from Allosteric Modulation of mGlu Receptors.
Stansley BJ; Conn PJ
Trends Pharmacol Sci; 2019 Apr; 40(4):240-252. PubMed ID: 30824180
[TBL] [Abstract][Full Text] [Related]
20. Investigating metabotropic glutamate receptor 5 allosteric modulator cooperativity, affinity, and agonism: enriching structure-function studies and structure-activity relationships.
Gregory KJ; Noetzel MJ; Rook JM; Vinson PN; Stauffer SR; Rodriguez AL; Emmitte KA; Zhou Y; Chun AC; Felts AS; Chauder BA; Lindsley CW; Niswender CM; Conn PJ
Mol Pharmacol; 2012 Nov; 82(5):860-75. PubMed ID: 22863693
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
